메뉴 건너뛰기




Volumn 42, Issue 2, 1998, Pages 263-268

Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX;

EID: 0031893392     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (75)

References (18)
  • 1
    • 0027139351 scopus 로고
    • Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B
    • Adler-Moore, J. P., and R. T. Proffitt. 1993. Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. J. Liposome Res. 3:429-450.
    • (1993) J. Liposome Res. , vol.3 , pp. 429-450
    • Adler-Moore, J.P.1    Proffitt, R.T.2
  • 2
    • 3042655225 scopus 로고
    • Fujisawa USA, Inc., Deerfield, Ill.
    • Anonymous. 1995. Data on file. Fujisawa USA, Inc., Deerfield, Ill.
    • (1995) Data on File
  • 3
    • 0014032869 scopus 로고
    • Pharmacology, toxicity, and therapeutic usefulness of amphotericin B
    • Buler, W. T. 1966. Pharmacology, toxicity, and therapeutic usefulness of amphotericin B. JAMA 195:127-131.
    • (1966) JAMA , vol.195 , pp. 127-131
    • Buler, W.T.1
  • 4
    • 0028335155 scopus 로고
    • Non-clinical studies of the efficacy, pharmacokinetics and safety of amphotericin B colloidal dispersion (ABCD)
    • Dayan, A. D., and P. K. Working. 1994. Non-clinical studies of the efficacy, pharmacokinetics and safety of amphotericin B colloidal dispersion (ABCD). Round Table Ser. R. Soc. Med. Press 32:12-26.
    • (1994) Round Table Ser. R. Soc. Med. Press , vol.32 , pp. 12-26
    • Dayan, A.D.1    Working, P.K.2
  • 5
    • 0025741787 scopus 로고
    • Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective
    • Fielding, R. M. 1991. Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective. Clin. Pharmacokinet. 21:155-164.
    • (1991) Clin. Pharmacokinet. , vol.21 , pp. 155-164
    • Fielding, R.M.1
  • 6
    • 0026595038 scopus 로고
    • Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs
    • Fielding, R. M., A. W. Singer, L. H. Wang, S. Babbar, and L. S. S. Guo. 1992. Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs. Antimicrob. Agents Chemother. 36:299-307.
    • (1992) Antimicrob. Agents Chemother. , vol.36 , pp. 299-307
    • Fielding, R.M.1    Singer, A.W.2    Wang, L.H.3    Babbar, S.4    Guo, L.S.S.5
  • 7
    • 0028140216 scopus 로고
    • Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: The potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection
    • Francis, P., L. W. Lee, A. Hoffman, J. Peter, A. Francesconi, J. Bacher, J. Shelhamer, P. Pizzo, and T. J. Walsh. 1994. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. J. Infect. Dis. 169:356-368.
    • (1994) J. Infect. Dis. , vol.169 , pp. 356-368
    • Francis, P.1    Lee, L.W.2    Hoffman, A.3    Peter, J.4    Francesconi, A.5    Bacher, J.6    Shelhamer, J.7    Pizzo, P.8    Walsh, T.J.9
  • 8
    • 0027314254 scopus 로고
    • Amphotericin B and its delivery by liposomal and lipid formulations
    • Gates, C., and R. J. Pinney. 1993. Amphotericin B and its delivery by liposomal and lipid formulations. J. Clin. Pharm. Ther. 18:147-153.
    • (1993) J. Clin. Pharm. Ther. , vol.18 , pp. 147-153
    • Gates, C.1    Pinney, R.J.2
  • 11
    • 0024474065 scopus 로고
    • Incorporation of amphotericin B (AMB) into liposomes alters the AMB-induced acute nephrotoxicity in rabbits
    • Joly, V., F. Dromer, J. Barge, P. Yeni, N. Seta, G. Molas, and C. Carbon. 1989. Incorporation of amphotericin B (AMB) into liposomes alters the AMB-induced acute nephrotoxicity in rabbits. J. Pharm. Exp. Ther. 251:311-316.
    • (1989) J. Pharm. Exp. Ther. , vol.251 , pp. 311-316
    • Joly, V.1    Dromer, F.2    Barge, J.3    Yeni, P.4    Seta, N.5    Molas, G.6    Carbon, C.7
  • 13
    • 0025821201 scopus 로고
    • Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in rats
    • Longuet, P., V. Joly, P. Amirault, N. Seta, C. Carbon, and P. Yeni. 1991. Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in rats. Antimicrob. Agents Chemother. 35:1303-1308.
    • (1991) Antimicrob. Agents Chemother. , vol.35 , pp. 1303-1308
    • Longuet, P.1    Joly, V.2    Amirault, P.3    Seta, N.4    Carbon, C.5    Yeni, P.6
  • 15
  • 16
    • 0026043820 scopus 로고
    • Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents
    • Proffitt, R. T., A. Sartorius, S. M. Chiang, L. Sullivan, and J. P. Adler-Moore. 1991. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J. Antimicrob. Chemother. 28(Suppl. B):49-61.
    • (1991) J. Antimicrob. Chemother. , vol.28 , Issue.SUPPL. B , pp. 49-61
    • Proffitt, R.T.1    Sartorius, A.2    Chiang, S.M.3    Sullivan, L.4    Moore, J.P.5
  • 17
    • 0028960767 scopus 로고
    • Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leukopenic mice infected with Candida albicans
    • van Eaten, E. W. M., M. Otte-Lambillion, W. van Vianen, M. T. ten Kate, and I. A. J. M. Bakker-Woudenberg. 1995. Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leukopenic mice infected with Candida albicans. J. Antimicrob. Chemother. 35:509-519.
    • (1995) J. Antimicrob. Chemother. , vol.35 , pp. 509-519
    • Van Eaten, E.W.M.1    Otte-Lambillion, M.2    Van Vianen, W.3    Ten Kate, M.T.4    Bakker-Woudenberg, I.A.J.M.5
  • 18
    • 0029017725 scopus 로고
    • Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy
    • Walsh, T. J., K. Garrett, E. Feuerstein, M. Girton, M. Allende, J. Bacher, A. Francesconi, R. Schaufele, and P. A. Pizzo. 1995. Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy. Antimicrob. Agents Chemother. 39:1065-1069.
    • (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 1065-1069
    • Walsh, T.J.1    Garrett, K.2    Feuerstein, E.3    Girton, M.4    Allende, M.5    Bacher, J.6    Francesconi, A.7    Schaufele, R.8    Pizzo, P.A.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.